Log in Open account
Australia
Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND] Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND] Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]

Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]

Macro 4 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Quasi-Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: Technical Check-in on the Equities Divergences on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]


Top of Mind…

  • As KVP gets back in the game, its been flagged by our world class Global Sales Trading Team - that we need more equity focus pieces for our clients... so we are just gonna check into three names that we've covered on the Macro Dragon before

  • As always, be wary of any equity analyst talking about equites, let alone the Macro Dude talking about equities... :)

  • Let’s start with the underperformer, BYND – which the Dragon has been covering for a whilst, since it actually listed. The Macro Skew on this was covered in Aug 2020; Erns Watch: Beyond Meat, Alternative Protein Theme & Macro Sins -  which touched on the Alternative Protein Space from a Meta Perspective.

  • KVP still has to catch-up with the latest fundamentals – previous quarter saw them continuing to invest in R&D & rebooting their European strategy, shifting from a partnership to driving it themselves. Next scheduled earnings date is after market on the Nov 10th

  • The chart & stock price has been ugly for the bulls & a delight for the bears – the 1Q spike was the GameStop/WSB/SME squeeze, followed by a similar smaller wave in the end of 2Q.

    BYND - 6m chart

  • Low for the year is $91.55 lvls, with key resistance likely being in the $120-130 range, from these $102 lvls. Its worth noting the short-interest as a % of the float is c. 28%, with c. 8x to cover as of 14 days ago. So we could see some shorts being covered as we approach the earnings date & a squeeze if there is an upbeat surprise. BYND has had 4 consecutive negative months where it has dropped from 157.49 to 98.98 for the close of Oct, that’s a -37% fall.

  • On the other hand, in just 1m alone Compass Pathways [CMPS] is up over +55%, in an example of where patience has paid off. We’ve touched on CMPS since its listing last year; Macro Dragon: Putting Compass on the Map... Mycelium, Magic Mushrooms + Psychedelics for Medicine & Treatment - with the key catalyst always being 2H21 on the results of the clinical trials.

    CMPS - 6m chart

  • The chart is breaking out big time past $40 previous resistance lvl. At $46.66, the next likely key lvls to test will be $50 & the all time high of c. $62. This is not a chart that KVP would be short, unless there was a specific event-driven catalyst as a play. Its worth noting that CMPS is set to report on Nov 12.

  • Lastly with at least no near-term earnings risk, we had AirBnB[ABNB] reporting yesterday, whilst it close dup +3.2% at 178.45, the results were post market & its currently looking indicated at 184.60/185.00, a c. +3-4% uplift on yest.’s close.

ABNB - 6m chart
 

  • The likely next key lvl to test on ABNB is $200, with support being offering at the $160 lvl. It will be interesting to see how it trades on this NFP Friday. Good wkd folks.

-

Start<>End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Position.

This is The Way

Namaste,
KVP

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 05

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article

  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article

  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article

  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article

  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia
Products & pricing
Asset Management
    Platforms
    Accounts & service
    General
    Other
    Legal

    Trading can result in losses. Please ensure you understand the risks.

    The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

    Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

    Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

    Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

    The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

    Please click here to view our full disclaimer.